Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin Inhalation Solution in Non-CF Bronchiectasis
NCT02657473Phase 3Completed
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Aug 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Noordwest Ziekenhuisgroep. Started Aug 2016; status: completed.
02
Drugs
tobramycin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02657473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02657473.